In the unvaccinated group, 10?mL blood was drawn for determining the baseline value of SARS-CoV-2 specific humoral and cellular immunity. induced in KTRs after administration of inactivated vaccine. Reduction of unconjugated bilirubin and tacrolimus concentration might benefit specific cellular immunity response Baicalein in KTRs following vaccination. Subject terms: Immunology, Risk factors Introduction Numerous studies have shown that solid organ transplant recipients (SOTRs) requiring lifelong maintenance immunosuppression have a higher risk of SARS-CoV-2 illness and severe COVID-19, actually for the less pathogenic omicron variants1,2. Given that vaccination is considered as one of the best strategies for curbing the COVID-19 pandemic, several nephrology societies have called for kidney transplant recipients (KTRs) to be prioritized for the administration of SARS-CoV-2 vaccine3. The security and efficacy of various SARS-CoV-2 vaccines in KTRs need to be extensively ascertained since these individuals have been excluded from most medical tests of SARS-CoV-2 vaccines4. Medical tests of mRNA vaccines have proven that humoral and cellular immunity responses were significantly reduced KTRs than in healthy individuals because of the receiving life-long immunosuppression regimens5,6. Studies have shown that three doses of mRNA vaccines could further enhance the antibody titers in SOTRs compared with two doses7. Concerning to inactivated vaccine, 11.6 billion vaccine doses have been given worldwide (45% worldwide), with 65C85% efficacy against symptomatic infection of ancestral strain8. Different from other technologies centered vaccine, such as protein subunits, viral vectors, and nucleic acid strategies (mRNA and DNA), which are mainly based on the spike protein being important for Rabbit Polyclonal to Merlin (phospho-Ser518) computer virus to entering into sponsor cells, the whole virus parts are presented to the immune system by administration of inactivated vaccine with an adjuvant9. Consequently, multi-protein-specific T cell response could be efficiently induced, even though magnitude of spike specific antibody and T cells level was significantly lower that induced by mRNA vaccine in general populations10. In addition, inactivated vaccines are relatively cheap and easy to produce, can be stored at 2C8?C that benefits worldwide vaccine supply, especially in under-developed country. Hopefully, recent data has shown that inactivated vaccines could induce specific cellular immunity response in some KTRs11. Moreover, an apparent different proportion of KTRs with positive seroconversion of SARS-CoV-2 specific antibody after second dose of inactivated vaccine have become reported as well11,12,16,17. Even that, the risk factors associated with the poor response to COVID-19 vaccination in KTRs are not well-defined13. Methods Subjects The study was conducted in accordance with the Declaration of Helsinki and was authorized by the Ethics Committee of the Second Affiliated Hospital of Guangzhou Medical University or college (Authorization No. 2021-hs-43). The medical trial protocol was registered with the Chinese Clinical Trial Registry (No. ChiCTR2100049037, Registrys Web address: https://www.chictr.org.cn/listbycreater.aspx). To comparative analysis of the SARS-CoV-2 specific immunity between KTRs and healthy participants (HPs) after administration of inactivated vaccine, KTRs and HPs, who had been administrated with inactivated vaccine or had not been vaccinated, were randomly recruited in the transplant center Baicalein from June 20, 2021 to August 20, 2021. A total of 163 subjects were enrolled and drawn the whole blood after second dose of inactivated vaccine or before vaccination after obtaining the educated consent. Of the 163 participants, 95 experienced received two doses of SARS-CoV-2 inactivated vaccine whereas 68 participants were unvaccinated. Of the 95 fully vaccinated participants, 43 were KTRs whereas 52 were HPs. In the unvaccinated group, 38 were KTRs whereas 30 were HPs. None of them of the participants in the unvaccinated group experienced a history suggestive of symptomatic COVID-19 illness. In the case of KTRs, the following data was extracted from your records: patients medical data including age, sex, medical history, medication history, kidney transplant time, body Baicalein mass index, hematologic guidelines (white blood cell counts, lymphocyte counts, platelet counts and hemoglobin), hepatic function (alanine aminotransferase, aspartate aminotransferase, and total bilirubin) and kidney function checks (serum creatinine, urine protein, and urine reddish cells). In the case of vaccinated individuals, the SARS-CoV-2 vaccine brand given and adverse effects (AEs), if any, were noted. Baicalein Sample processing Among the vaccinated participants, 10?mL blood was collected from 40 KTRs and 48 HPs between 20??5?days after the second dose of vaccine. Of.